Focus on Diabetes   /     Type 1 Diabetes & the Role of Anti-CD3 Targeted Therapy

Shownotes

Guest: Kevan C. Herold, MD
Guest: Chantal Mathieu, MD, PhD

Experts in the immunopathology of type 1 diabetes discuss the epidemiology, non-genetic and genetic risk factors, and progression from preclinical to clinical stages of this disease. The discussion will emphasize the breakdown of immune tolerance that precedes type 1 diabetes and the subsequent pathogenetic role of islet autoantibodies responsible for its clinical manifestations.